TCT 2026 | October 31–November 3 | San Diego

Meet the AQMed Team at TCT 2026

We’re in San Diego to share new magnetocardiography research and showcase our investigational cardiac device for mapping the heart’s magnetic field at bedside.

Schedule a Conversation at TCT

Share a few details and we’ll follow up to find a time during the conference.

Research Presented at TCT

See what the AQMed team and our clinical collaborators are presenting in San Diego.

TCT #25

Direct Visualization of ECG-Silent Ischemic Injury Currents Using a Mobile, Unshielded Magnetocardiography Array

Brian Cottle, PhD

Study of ECG-silent ischemic injury currents using a mobile, unshielded magnetocardiography array.

TCT #1013

Detecting High-Risk Coronary Artery Disease with Mobile Unshielded Magnetocardiography: Early Results from PRISM2 Feasibility Study

Agata Sularz, MD (support: Rezwan Ahmed)

Early results from the PRISM2 feasibility study of mobile, unshielded magnetocardiography in high-risk coronary artery disease.

Presented at ACC 2026

Evaluating Unshielded Magnetocardiography for Acute Coronary Syndrome Triage

A study with Mount Sinai evaluating unshielded magnetocardiography in the triage of patients with suspected acute coronary syndrome.

Evaluating Unshielded Magnetocardiography for Acute Coronary Syndrome Triage

A study with Mount Sinai evaluating unshielded magnetocardiography in the triage of patients with suspected acute coronary syndrome.

Find Us at TCT

Our team is at TCT from October 31 through November 3. Catch our presentations or request a time to meet.

November 1, 8:20–8:26 AM

TCT 25: Direct Visualization of ECG-Silent Ischemic Injury Currents Using a Mobile, Unshielded Magnetocardiography Array

Brian Cottle, PhD | Station 5, Halls C–G, Ground Level

November 2, 3:40–3:46 PM

TCT 1013: Detecting High-Risk Coronary Artery Disease with Mobile Unshielded Magnetocardiography: Early Results from PRISM2 Feasibility Study

Agata Sularz, MD (support: Rezwan Ahmed) | Station 4, Halls C–G, Ground Level

To view an abstract, find the session number on the TCT program page and select “View Abstract.”

About CardiAQ

AQMed is SandboxAQ’s medical technology initiative, combining advanced sensors with AI. CardiAQ is an investigational magnetocardiography (MCG) device that measures the magnetic fields produced by the heart’s electrical activity.

CardiAQ is designed to work without a magnetically shielded room. AI filters out ambient magnetic noise, so scans can happen in a busy hospital environment.

CAUTION Investigational device. Limited by Federal (or United States) law to investigational use.